KLOW
GHK-CU 50mg, TB-500 10mg, BPC-157 10mg, KPV 10mg recovery stack
Select size
For research purposes only. Not for human consumption.
Mechanism of Action
An advanced recovery and anti-inflammatory research stack combining BPC-157, TB-500, GHK-Cu, and KPV — four peptides addressing tissue repair, immune modulation, and inflammatory pathway regulation.
How It Works
- 1
BPC-157 (10mg) promotes angiogenesis and accelerates musculoskeletal tissue repair
- 2
TB-500 (10mg) enhances cell migration and reduces pro-inflammatory cytokines
- 3
GHK-Cu (50mg) upregulates collagen synthesis and activates tissue remodeling genes
- 4
KPV (10mg) is an alpha-MSH fragment that potently suppresses NF-κB inflammatory signaling
- 5
Quadruple combination addresses repair, remodeling, and inflammation through four distinct mechanisms
Key Research Benefits
- Quad-peptide formula
- Anti-inflammatory (KPV) addition
- Comprehensive recovery support
- NF-κB pathway modulation
KLOW builds on the GLOW stack by adding KPV, a potent anti-inflammatory tripeptide derived from alpha-MSH. This addition targets NF-κB-mediated inflammation, making it ideal for researchers studying chronic inflammatory conditions alongside tissue repair.